Mike McDermott, MD, is president and CEO of Mary Washington Healthcare in Fredericksburg, Va. He is a diagnostic and interventional radiologist who served in a variety of leadership and governance ...

(Open Cosmos PR) — Open Cosmos – the leading SpaceTech startup simplifying access to space to help solve the world’s biggest challenges is today launching DataCosmos, its multi-satellite data platform ...

Open Cosmos, a UK space tech startup, has raised $50 million in fresh funding. Founded in 2015, Open Cosmos had only raised $7 million previously. The company uses satellites to track and monitor ...

At this year’s World Satellite Business Week in Paris, Accenture (NYSE:ACN) announced an investment and collaboration with Open Cosmos, a space technology company that focuses on the design, ...

COSMOS-Web was the largest General Observer program selected by the James Webb Space Telescope for Cycle 1. The team, led by RIT Associate Professor Jeyhan Kartaltepe, has publicly released its full ...

Cosmos Data Technologies, the official reporting and analytics platform built specifically for Microsoft Dynamics 365 Business Central cloud, today announced native connectivity to Microsoft Dataverse ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

New Models Enable Prediction, Controllable World Generation and Reasoning for Physical AI Two New Blueprints Deliver Massive Physical AI Synthetic Data Generation for Robot and Autonomous Vehicle Post ...

New ways to bring MongoDB data and apps to Azure Cosmos DB Your email has been sent Branded as Microsoft’s “planetary scale database,” Cosmos DB is one of Azure’s foundational services, powering its ...

SAN JOSE, Calif., April 26, 2023 – Tredence, a data science and AI solutions company, today announced that its Customer Cosmos solution was named “Data Visualization Solution of the Year” in the ...

Please provide your email address to receive an email when new articles are posted on . Guselkumab 100 mg administered every 8 weeks results in “significantly higher” ACR20 response rates vs. placebo ...